[
    {
        "source": "Inflammatory bowel disease (IBD)",
        "target": "Infliximab",
        "relationship": "treated with",
        "description": "IBD patients are treated with the TNF antagonist infliximab."
    },
    {
        "source": "Infliximab",
        "target": "ALOX15",
        "relationship": "modulates",
        "description": "Infliximab treatment influenced the expression of ALOX15 in the study."
    },
    {
        "source": "Infliximab",
        "target": "FCER1A",
        "relationship": "modulates",
        "description": "Infliximab treatment influenced the expression of FCER1A in the study."
    },
    {
        "source": "Infliximab",
        "target": "OLIG2",
        "relationship": "modulates",
        "description": "Infliximab treatment influenced the expression of OLIG2 in the study."
    }
]